- Home
- BRDG vs JSPR Comparison
BRDG vs JSPR Comparison
Compare BRDG & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRDG
- JSPR
- Stock Information
- Founded
- BRDG 2009
- JSPR 2018
- Country
- BRDG United States
- JSPR United States
- Employees
- BRDG N/A
- JSPR 45
- Industry
- BRDG Investment Managers
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BRDG Finance
- JSPR Health Care
- Exchange
- BRDG Nasdaq
- JSPR Nasdaq
- Market Cap
- BRDG 355.4M
- JSPR 323.6M
- IPO Year
- BRDG 2021
- JSPR N/A
- Fundamental
- Price
- BRDG $8.58
- JSPR $21.57
- Analyst Decision
- BRDG Buy
- JSPR Strong Buy
- Analyst Count
- BRDG 7
- JSPR 11
- Target Price
- BRDG $10.64
- JSPR $73.38
- AVG Volume (30 Days)
- BRDG 168.1K
- JSPR 181.9K
- Earning Date
- BRDG 02-19-2025
- JSPR 11-07-2024
- Dividend Yield
- BRDG 4.94%
- JSPR N/A
- EPS Growth
- BRDG N/A
- JSPR N/A
- EPS
- BRDG 0.09
- JSPR N/A
- Revenue
- BRDG $404,932,000.00
- JSPR N/A
- Revenue This Year
- BRDG $30.24
- JSPR N/A
- Revenue Next Year
- BRDG $24.98
- JSPR N/A
- P/E Ratio
- BRDG $98.20
- JSPR N/A
- Revenue Growth
- BRDG 63.66
- JSPR N/A
- 52 Week Low
- BRDG $6.18
- JSPR $5.00
- 52 Week High
- BRDG $11.69
- JSPR $31.01
- Technical
- Relative Strength Index (RSI)
- BRDG 23.27
- JSPR 48.67
- Support Level
- BRDG $9.21
- JSPR $20.12
- Resistance Level
- BRDG $9.02
- JSPR $23.11
- Average True Range (ATR)
- BRDG 0.25
- JSPR 1.77
- MACD
- BRDG -0.12
- JSPR -0.16
- Stochastic Oscillator
- BRDG 4.29
- JSPR 32.53
About BRDG Bridge Investment Group Holdings Inc.
Bridge Investment Group Holdings Inc is a vertically integrated investment manager, diversified across specialized asset classes. The company combines its nationwide operating platform with dedicated teams of investment professionals focused on various specialized and synergistic investment platforms, including real estate, credit, renewable energy, and secondaries strategies. Its broad range of products and vertically integrated structure allow it to capture new market opportunities and serve investors with various investment objectives. The company operates Its business in a single segment, alternative investment management, diversified across specialized and synergistic investment platforms.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.